ENZ - Enzo Biochem, Inc.
2.5900 0.00 (0.00%)
After hours: 4:17PM EST
| Previous Close | 2.5500 |
| Open | 2.5500 |
| Bid | 2.5900 x 1000 |
| Ask | 2.7100 x 800 |
| Day's Range | 2.5450 - 2.6541 |
| 52 Week Range | 2.4000 - 4.4600 |
| Volume | 116,276 |
| Avg. Volume | 81,274 |
| Market Cap | 123.172M |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | 172.67 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
How Does Enzo Biochem, Inc. (NYSE:ENZ) Affect Your Portfolio Volatility?
Anyone researching Enzo Biochem, Inc. (NYSE:ENZ) might want to consider the historical volatility of the share price...
- Insider Monkey
Is Enzo Biochem, Inc. (ENZ) Going To Burn These Hedge Funds ?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The last 12 months is one of those periods, as the Russell 2000 […]
- Simply Wall St.
What Kind Of Shareholders Own Enzo Biochem, Inc. (NYSE:ENZ)?
Every investor in Enzo Biochem, Inc. (NYSE:ENZ) should be aware of the most powerful shareholder groups. Institutions...
- Thomson Reuters StreetEvents
Edited Transcript of ENZ earnings conference call or presentation 15-Oct-19 8:30pm GMT
Q4 2019 Enzo Biochem Inc Earnings Call
- Simply Wall St.
Does Enzo Biochem, Inc.'s (NYSE:ENZ) CEO Salary Reflect Performance?
Elazar Rabbani became the CEO of Enzo Biochem, Inc. (NYSE:ENZ) in 1976. This report will, first, examine the CEO...
- Simply Wall St.
Investors Who Bought Enzo Biochem (NYSE:ENZ) Shares Five Years Ago Are Now Down 41%
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
- Simply Wall St.
Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
- Simply Wall St.
Is Enzo Biochem, Inc.'s (NYSE:ENZ) 2.3% ROE Worse Than Average?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Thomson Reuters StreetEvents
Edited Transcript of ENZ earnings conference call or presentation 11-Jun-19 12:30pm GMT
Q3 2019 Enzo Biochem Inc Earnings Call
- Simply Wall St.
What Kind Of Share Price Volatility Should You Expect For Enzo Biochem, Inc. (NYSE:ENZ)?
If you're interested in Enzo Biochem, Inc. (NYSE:ENZ), then you might want to consider its beta (a measure of share...
- MoneyShow
Biotech Bets and a Goodbye from a Favorite Expert
After nearly 38 years, small cap, biotech expert Bill Mathews is retiring as editor of The Cheap Investor; we wish Bill and his wife Karen the very best for their coming years. Meanwhile, we leave our readers with some of Bill's parting comments on some of his favorite biotech ideas.
- Simply Wall St.
What Percentage Of Enzo Biochem, Inc. (NYSE:ENZ) Shares Do Insiders Own?
A look at the shareholders of Enzo Biochem, Inc. (NYSE:ENZ) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the small...
- Thomson Reuters StreetEvents
Edited Transcript of ENZ earnings conference call or presentation 12-Mar-19 12:30pm GMT
Q2 2019 Enzo Biochem Inc Earnings Call
- Associated Press
Enzo Biochem: Fiscal 2Q Earnings Snapshot
On a per-share basis, the New York-based company said it had a loss of 18 cents. The life sciences and biotechnology company posted revenue of $19.3 million in the period. In the final minutes of trading ...
- Simply Wall St.
Why Enzo Biochem, Inc.’s (NYSE:ENZ) CEO Pay Matters To You
In 1976 Elazar Rabbani was appointed CEO of Enzo Biochem, Inc. (NYSE:ENZ). First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth thatRead More...
